Is Zevra Therapeutics, Inc. (ZVRA) a Buy, Sell, or Hold?
NASDAQ : ZVRA
Zevra Therapeutics, Inc.
$12.92 USD
$0.16 (1.25%)
- Volume
- 321.12K
- Average Volume
- 1.69M
- Market Capitalization
- $763.77M
- P/E Ratio
- 5.93
- Dividend Yield
- 0.00%
- Price Target
- $29.00
- Year High
- $15.04
- Year Low
- $7.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.89
Analyst Consensus Summary
Consensus Rating
Buy
10 Analysts
Rating Score
4/5
Recommendation Strength
Upside/Downside
-55.4%
vs Current Price
Price Target
$29.00
Average TargetPrice Target Range
Lowest Target
$29.00
-55.4% DOWNSIDE
Average Target
$29.00
Median Estimate
Highest Target
$35.00
-63.1% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 10
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 10 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Maxim Group | Jason McCarthy | $35 | $13.6673 | 2026-06-10 01:32 PM | 156.1% |
| Guggenheim | Eddie Hickman | $29 | $13.66 | 2026-06-10 06:52 AM | 112.3% |
| Canaccord Genuity | Sumant Kulkarni | $29 | $12.09 | 2026-06-09 06:50 AM | 139.9% |
| Guggenheim | Eddie Hickman | $25 | $11 | 2026-05-08 07:15 AM | 127.3% |
| Guggenheim | Eddie Hickman | $23 | $11.03 | 2026-03-10 06:40 AM | 108.5% |
| H.C. Wainwright | Brandon Folkes | $26 | $8.82 | 2025-12-30 06:38 AM | 194.8% |
| Cantor Fitzgerald | Kristen Kluska | $24 | $9.285 | 2025-11-06 09:04 AM | 158.5% |